Keywords: pfizer, may, counter, daiichi, sankyo, bid, ranbaxy

Pfizer may counter Daiichi Sankyo bid for Ranbaxy

Article | 23 June 2008

Print This

Global drug giant Pfizer may make a counter-bid for India's Ranbaxy Laboratories against Japanese drugmaker Daiichi Sankyo's $4.6 billion offer.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in